| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 99.414 | 90.834 | 262.972 | 174.625 | 180.476 | 192.018 | 714.916 | 955.840 | 1.262.821 | 1.223.498 |
| Total Income - EUR | 99.415 | 90.835 | 262.974 | 174.625 | 180.477 | 192.019 | 714.924 | 955.881 | 1.263.092 | 1.223.573 |
| Total Expenses - EUR | 52.590 | 64.398 | 74.686 | 61.155 | 81.700 | 179.161 | 649.378 | 729.128 | 1.014.787 | 1.164.305 |
| Gross Profit/Loss - EUR | 46.825 | 26.437 | 188.287 | 113.470 | 98.777 | 12.858 | 65.546 | 226.753 | 248.306 | 59.268 |
| Net Profit/Loss - EUR | 39.333 | 25.529 | 183.346 | 111.724 | 96.972 | 10.938 | 59.254 | 217.395 | 213.831 | 48.025 |
| Employees | 6 | 7 | 8 | 8 | 8 | 7 | 15 | 19 | 23 | 24 |
Check the financial reports for the company - Dr. Irimia Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 129.736 | 128.259 | 127.136 | 135.248 | 132.335 | 185.097 | 177.707 | 175.662 | 171.665 | 229.478 |
| Current Assets | 30.697 | 25.881 | 170.194 | 111.666 | 74.637 | 108.586 | 147.597 | 326.798 | 252.645 | 93.521 |
| Inventories | 191 | 189 | 185 | 182 | 178 | 45.723 | 3.263 | 4.892 | 121 | 120 |
| Receivables | 16.711 | 19.336 | 48.767 | 123.401 | 35.797 | 39.930 | 100.076 | 234.219 | 194.947 | 51.248 |
| Cash | 13.796 | 6.357 | 121.242 | -11.917 | 38.662 | 22.933 | 44.259 | 87.687 | 57.578 | 42.153 |
| Shareholders Funds | 40.180 | 65.299 | 222.444 | 158.699 | 143.038 | 47.861 | 106.054 | 313.049 | 140.638 | 52.211 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 120.253 | 88.841 | 74.887 | 88.214 | 63.934 | 245.823 | 219.250 | 190.388 | 284.645 | 272.786 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dr. Irimia Srl